The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of elderly patients with resectable liver metastases from colorectal cancer (CRLM): Single center experience.
 
Laura Mansour
No Relationships to Disclose
 
Rami Mohamad Nassabein
No Relationships to Disclose
 
Filip Gryspeerdt
No Relationships to Disclose
 
Franck Vandenbroucke-Menu
No Relationships to Disclose
 
Francine Aubin
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb/Medarex; Bristol-Myers Squibb/Medarex; Bristol-Myers Squibb/Medarex; Bristol-Myers Squibb/Medarex; Shire; Shire; Shire; Shire; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Bristol-Myers Squibb/Medarex (Inst); Bristol-Myers Squibb/Medarex (Inst); Bristol-Myers Squibb/Medarex (Inst)
 
Jean-Pierre M. Ayoub
Honoraria - Eisai; Eisai; Eisai; Eisai; Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; NanoString Technologies; NanoString Technologies; NanoString Technologies; NanoString Technologies; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer
Speakers' Bureau - Eisai; Eisai; Eisai; Eisai; Roche; Roche; Roche; Roche
Research Funding - Abbvie; Abbvie; Abbvie; Abbvie; Celgene; Celgene; Celgene; Celgene; Novartis; Novartis; Novartis; Novartis; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Tesaro; Tesaro; Tesaro; Tesaro
 
Michel Dagenais
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; Ipsen; Ipsen; Ipsen; Ipsen
Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen
Research Funding - Concordia; Concordia; Concordia; Concordia
 
Real W. Lapointe
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis
 
Richard Letourneau
No Relationships to Disclose
 
Marylene Plasse
No Relationships to Disclose
 
Andre Roy
No Relationships to Disclose
 
Simon Turcotte
Honoraria - Lilly; Lilly; Lilly; Lilly
Consulting or Advisory Role - Exactis Innovation; Exactis Innovation; Exactis Innovation; Exactis Innovation; TVM Capital Life Science; TVM Capital Life Science; TVM Capital Life Science; TVM Capital Life Science
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Surface Oncology; Surface Oncology; Surface Oncology; Surface Oncology
 
Mustapha Tehfe
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Merck; Merck; Merck; Merck; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Merck; Merck; Merck; Merck; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Takeda; Takeda; Takeda
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene
Research Funding - Celgene; Celgene; Celgene; Celgene